Who To Contact

Baptist MD Anderson
Cancer Center
1301 Palm Avenue
Jacksonville, FL 32207

Poonam K. Neki, MBBS,DA, CCRP
Research Director
Baptist MD Anderson Clinical Trials
904.202.7468
poonam.neki@bmcjax.com

Clinical Trial ID: NCT04895358

A Randomized, Double-blind, Placebo-controlled, Phase 3 Study of Pembrolizumab Plus Chemotherapy Versus Placebo Plus Chemotherapy for he Treatment of Chemotherapy-Candidate Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative (HR+/HER2-) Locally Recurrent Inoperable or Metastatic Breast Cancer (KEYNOTE-B49)

Status

Open

Conditions

Other

Phases

III

Age Group

Adult

Main Investiagtor

Crozier, Jennifer

Practice

Breast

Scope

National

Participating Institutions

Baptist MD Anderson Cancer Center

Nct ID Number

NCT04895358

Secondary Trial ID Number

MK-3475-B49-0013

Keywords

Treatment